Cargando…

Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study

PURPOSE: Recent clinical trials have demonstrated that zoledronic acid (ZOL) significantly prolongs survival in prostate cancer patients undergoing androgen deprivation therapy. This pilot study investigated the influence of ZOL on circulating tumor cell (CTC) counts in prostate cancer patients in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ide, Hisamitsu, Lu, Yan, Tanaka, Toshiaki, Wakumoto, Yoshiaki, Kitamura, Kosuke, Muto, Satoru, Yamaguchi, Raizo, Masumori, Naoya, Horie, Shigeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society (APPS) 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186959/ https://www.ncbi.nlm.nih.gov/pubmed/25325027 http://dx.doi.org/10.12954/PI.14056

Ejemplares similares

Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy
por: Kitamura, Kosuke, et al.
Publicado: (2019)

A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience
por: Muto, Satoru, et al.
Publicado: (2017)

Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens
por: Kitamura, Kosuke, et al.
Publicado: (2014)

The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate
por: Saito, Keisuke, et al.
Publicado: (2015)

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
por: Ieda, Takeshi, et al.
Publicado: (2016)

Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2013)

Port site hernia at the robotic arm port after robotic‐assisted laparoscopic radical prostatectomy
por: Ogasa, Taiki, et al.
Publicado: (2020)

Interferon-α Treatment for Growing Teratoma Syndrome of the Testis
por: Inoue, Masahiro, et al.
Publicado: (2013)

The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer
por: Muto, Satoru, et al.
Publicado: (2021)

Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review
por: Isotani, Shuji, et al.
Publicado: (2015)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2018)

PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease
por: Kimura, Tomoki, et al.
Publicado: (2023)

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
por: Nagaya, Naoya, et al.
Publicado: (2020)

The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma
por: Nagaya, Naoya, et al.
Publicado: (2018)

Clinical Usefulness of Corticotropin Releasing Hormone Testing in Subclinical Cushing's Syndrome for Predicting Cortisol Replacement after Adrenalectomy
por: Inoue, Masahiro, et al.
Publicado: (2012)

Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases
por: Hirano, Hisashi, et al.
Publicado: (2023)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

A Japanese Box Lunch Bento Comprising Functional Foods Reduce Oxidative Stress in Men: A Pilot Study
por: Ide, Hisamitsu, et al.
Publicado: (2022)

Impact of Pretreatment Total Cholesterol Level Is Associated With Metastasis of Prostate Cancer
por: Hirano, Hisashi, et al.
Publicado: (2020)

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
por: Nagata, Masayoshi, et al.
Publicado: (2016)

Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up
por: Horiuchi, Akira, et al.
Publicado: (2016)

Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model
por: Abdelhamed, Amr, et al.
Publicado: (2015)

Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer
por: Ashizawa, Takeshi, et al.
Publicado: (2022)

Robot-Assisted Radical Cystectomy with Modified Vesica Ileale Padovana (VIP) Neobladder Configuration Using a Hybrid Approach: Initial Experience
por: Shimizu, Fumitaka, et al.
Publicado: (2023)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy
por: Ohtaka, Ayako, et al.
Publicado: (2019)

Efficacy of Testosterone Treatment in Hemodialysis Patients as Assessed by Aging Males’ Symptoms Scores: A Pilot Study
por: Inoue, Yasuyuki, et al.
Publicado: (2018)

Effect of a urinary catheter on seed position and rectal and bladder doses in CT-based post-implant dosimetry for prostate cancer brachytherapy
por: Kunogi, Hiroaki, et al.
Publicado: (2015)

Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancer
por: Niraula, Saroj, et al.
Publicado: (2017)

Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer
por: Fukuda, Kazuhiro, et al.
Publicado: (2022)

Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant 7 Expression in Circulating Tumor Cells: A Case Report
por: Nagaya, Naoya, et al.
Publicado: (2020)

Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan
por: Muto, Satoru, et al.
Publicado: (2021)

Late Recurrence and Second Primary Malignancy among 139 Patients with Germ Cell Tumors: Long-term Outcome of the Disease in a Single-center Experience
por: Sato, Shunsuke, et al.
Publicado: (2010)

Comparison of Laparoscopic, Hand-Assisted, and Open Surgical Nephroureterectomy
por: Kitamura, Hiroshi, et al.
Publicado: (2014)

Heat Shock Protein 90α Is a Potential Serological Biomarker of Acute Rejection after Renal Transplantation
por: Maehana, Takeshi, et al.
Publicado: (2016)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
por: Muto, Satoru, et al.
Publicado: (2017)

Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era
por: Shibamori, Kosuke, et al.
Publicado: (2021)

Clinical characteristics and treatment outcomes of patients with small cell carcinoma of the urinary bladder
por: Muranaka, Takashi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6obohq0vufc9jml9j4q6fculfr